Edwards Lifesciences has received FDA approval for the Edwards SAPIEN 3 transcatheter valve system with the Alterra adaptive prestent. The Edwards SAPIEN 3 System is intended to treat adult patients with severe pulmonary regurgitation who have a native or surgically repaired right ventricular outflow tract and are indicated for pulmonary valve replacement.
Edwards Lifesciences has received FDA approval for the Edwards SAPIEN 3 transcatheter valve system with the Alterra adaptive prestent. The Edwards SAPIEN 3 System is intended to treat adult patients with severe pulmonary regurgitation who have a native or surgically repaired right ventricular outflow tract and are indicated for pulmonary valve replacement. 
ir.edwards.com
English (US) 